Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Mey

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Swiss Medical Weekly|May 12, 2010
Integrating novel agents into multiple myeloma treatment - current status in Switzerland and treatment recommendationsC Taverna, M Bargetzi, D Betticher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2020
Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upB Eichhorst, T Robak, E Montserrat, et al.
Blood Cancer Journal|August 29, 2019
Nelfinavir and lenalidomide/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I/II Trial (SAKK 39/10)F Hitz, M Kraus, T Pabst, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 7, 2021
Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>†</sup>M A Dimopoulos, P Moreau, E Terpos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 9, 2022
Corrigendum to "Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up'": [Ann Oncol Volume 33, Issue 1, January 2022, Page 117]M A Dimopoulos, P Moreau, E Terpos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 2021
Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up': [Ann Oncol 2021; 32(3): 309-322]M A Dimopoulos, P Moreau, E Terpos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 7, 2023
Impact of individualized treatment on recovery from fatigue and return to work in survivors of advanced-stage Hodgkin's lymphoma: results from the randomized international GHSG HD18 trialJ Ferdinandus, H Müller, C Damaschin, et al.
Hematological Oncology|December 10, 2020
Clinical characteristics and outcome of patients over 60 years with Hodgkin lymphoma treated in SwitzerlandA A Moccia, S Aeppli, S Güsewell, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Swiss Medical Weekly|May 12, 2010
Integrating novel agents into multiple myeloma treatment - current status in Switzerland and treatment recommendationsC Taverna, M Bargetzi, D Betticher, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 22, 2020
Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upB Eichhorst, T Robak, E Montserrat, et al.
Blood Cancer Journal|August 29, 2019
Nelfinavir and lenalidomide/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I/II Trial (SAKK 39/10)F Hitz, M Kraus, T Pabst, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 7, 2021
Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up<sup>†</sup>M A Dimopoulos, P Moreau, E Terpos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 9, 2022
Corrigendum to "Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up'": [Ann Oncol Volume 33, Issue 1, January 2022, Page 117]M A Dimopoulos, P Moreau, E Terpos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 2021
Corrigendum to 'Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up': [Ann Oncol 2021; 32(3): 309-322]M A Dimopoulos, P Moreau, E Terpos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 7, 2023
Impact of individualized treatment on recovery from fatigue and return to work in survivors of advanced-stage Hodgkin's lymphoma: results from the randomized international GHSG HD18 trialJ Ferdinandus, H Müller, C Damaschin, et al.
Hematological Oncology|December 10, 2020
Clinical characteristics and outcome of patients over 60 years with Hodgkin lymphoma treated in SwitzerlandA A Moccia, S Aeppli, S Güsewell, et al.
Pageof 5